News & Events

For exciting news click on one of the topics below!

Every year BIOKÉ speaks at professional seminars and comes to world wide exhibitions in the life science industry.

Are you eager to meet us? On the left sidebar our events calendar is shown, hope to see you next time!

• Reflecting on a wonderful WOTS fair

  LEIDEN October 11, 2024 - At the end of September, our team participated in the WoTS fair at Jaarbeurs Utrecht. We are reflecting on a successful event! We showcased the Western Blot solutions from our new brand, e-Blot, along with the latest version of the Labcycler by Sensoquest, among other innovations. It was a pleasure to engage with our loyal customers and establish numerous new connections in the industry. Be sure to watch our aftermovie.
• BIOKÉ will present new instruments at the WoTS fair

  UTRECHT September 23, 2024 - BIOKÉ will be at the bi-yearly World of Technology & Science fair, and we can't wait to show you our latest brand, e-Blot, along with our other exciting innovations. Curious about the new Labcycler PRO from Sensoquest or the CASYvivo from OLS? There's so much more to discover at our booth.
• BIOKÉ and e-BLOT announce a distribution agreement in the European region

  LEIDEN September 16, 2024 - BIOKÉ, a leading distributor of life science technologies throughout Europe for more than 20 years and a business unit of Cell Signaling Technology (CST) Europe, has partnered with e-BLOT, a leading supplier of biomedical innovation tools and solutions, to distribute their Western Blot devices across Netherlands, Belgium, Luxembourg, England, Ireland, Germany, Austria, Denmark, Norway, Finland and Iceland.
• Happy Holidays Pop-Up Bar

  LEIDEN December 11, 2023 - The end of the year is approaching quickly. We would like to invite you to explore our virtual Happy Holidays pop-up bar, where you can uncover our latest brands, interact with our team to discuss your projects, and request some goodies. And make sure not to miss out on the game, where you could have the opportunity to win one of our fancy orange labcoats. We are eagerly looking forward to welcoming you at our pop-up bar!
• Office Closure 2023

  LEIDEN, December 7, 2023 - We want to sincerely thank you for your support and partnership throughout 2023. As the year comes to a close, we would like to wish you a joyous holiday season filled with peace and cheer. We eagerly anticipate the opportunity to collaborate with you again in 2024. Kindly note that the BIOKÉ team will be taking some time off to spend with their loved ones from December 27th, 2023, until January 1st, 2024. We will be back and ready to kick-start the new year with you on Tuesday, January 2nd, 2024.
• Green Friday: For every like, we plant a tree

  Green is the new black! BIOKÉ joins the positive Green Friday movement initiated by Trees for All. No Black Friday deals and overconsumption, but investing in a sustainable and green world. Join us! For every 10 likes on our Green Friday post on LinkedIn, BIOKÉ donates a tree for the Green Friday Forest, in cooperation with Trees for All.
• Come by and share and gain new knowledge during the LabNL fair

  Leiden, July 4, 2023 - You don't want to miss this new event! You may have seen the news pass by: the new LabNL fair will be held in September 2023. Don't forget to sign up to ensure a valuable visit.
  
• BIOKÉ and Atrandi Biosciences announce a distribution agreement for the Benelux countries.

  LEIDEN July 3, 2023 - BIOKÉ has partnered with Atrandi Biosciences (Atrandi), an innovator in the field of microfluidics, to distribute technologies supporting high-throughput, single-cell analysis across the Benelux region. By combining BIOKÉ's extensive distribution network with Atrandi's pioneering microfluidic technologies, this agreement, which is effective immediately, will provide researchers in the Benelux countries with access to the latest tools for unraveling the mysteries of single cells and molecules.
• BIOKÉ and Scale Biosciences announce a distribution agreement for the Benelux countries.

  LEIDEN June 2, 2023 - BIOKÉ announced it has signed a distribution agreement with Scale Biosciences (ScaleBio), a pioneer in single-cell sequencing and combinatorial indexing technologies, to distribute their technology in the Netherlands, Belgium, and Luxembourg (Benelux), effective immediately.
• BIOKÉ and Byonoy announce a distribution agreement for the Benelux countries

  LEIDEN 6th April, 2023 - BIOKÉ announced it has signed a distribution agreement with Byonoy to distribute their technology in the Netherlands, Belgium, and Luxembourg (Benelux), effective immediately. Byonoy is a company that pioneers in creating laboratory instruments that are more intuitive, flexible, and compact than traditional devices, with the aim of simplifying the workflow for its users.

• BIOKÉ and Telesis Bio announce a distribution agreement for the Benelux countries

  LEIDEN 30th March, 2023 - BIOKÉ announced it has signed a distribution agreement with Telesis Bio to distribute their technology in the Netherlands, Belgium, and Luxembourg (Benelux), effective immediately. Telesis Bio is revolutionizing the synthetic biology landscape, enabling researchers to accelerate the development of innovative solutions to address some of the most pressing challenges facing humanity.

• Cell Signaling Technology becomes 1% for the Planet Lighthouse Member

  DANVERS, MA - April 19, 2022 - Cell Signaling Technology (CST), a discovery technology company and leading provider of antibodies, kits, and services, is the first life sciences company to join 1% for the Planet, committing to donate 1% of annual end-user product sales to support nonprofit organizations focused on the environment.
• BIOKÉ and Applied Cells announce a distribution agreement for the Benelux countries

  LEIDEN March 14, 2022 - BIOKÉ announced it has signed a distribution agreement with Applied Cells Inc to distribute the MARS® technology in the Netherlands, Belgium, and Luxembourg (Benelux), effective immediately. Applied Cells is a leading provider of cell preparation and isolation solutions for tumor biology research. Their proprietary innovative MARS platform, short-named after “Multi-physics Automated Reconfigurable Separation”, is ideal for gentle, high-efficiency, high-recovery, automated cell separation and sample preparation. The broad selection of MARS configurations provides flexibility to meet versatile workflows for rare cell analysis, immune cell profiling, and cell therapy, with capabilities including target cell enrichment, cell purification, and cell concentration.

• Visit our BIOKÉ Virtual Booth

  LEIDEN, January 17, 2022 - Blue Monday? Visit our virtual BIOKÉ booth this week. Your account managers will be there together with our technical support team to answer all your questions. Have a nice chat with our specialists, find your instrument solutions and win a CASY Cell Counter. Finish your tour by playing the "Try your luck in our lab" game to win a fun goodie.
• Mission Bio Launches Single-Cell Multi-omics Solutions to Help Advance Better, Safer Cell & Gene Therapies

  SOUTH SAN FRANCISCO, October 12, 2021 - Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has launched Tapestri Cell & Gene Therapy Solutions, enabling deep analytical characterization of genotype with phenotype simultaneously for quicker, more efficient workflows. Through these one-of-a-kind assays and capabilities, cell and gene therapy companies can begin measuring multiple attributes simultaneously in the same cells, enabling novel insights to power research from discovery through the clinic.
• Go Green! Our new Carton Boxes

  At BIOKÉ we continue to strive to reduce our environmental footprint. New specially designed carton boxes for cold shipments will help to reduce waste. Swapping our smallest styrofoam boxes with recyclable carton boxes has enabled an 80% reduction of styrofoam usage. We can be environmentally conscious while safeguarding performance.
• Visit our NEB Virtual Booth

  LEIDEN, May 31, 2021 - As we are still not able to meet in person nowadays, we have organized another virtual booth together with New England Biolabs. Take a look around, browse the folders and don't forget to request the brand-new NEB catalog, we will ship it to you including a small surprise :).
• Resistance Mechanisms to FLT3 Inhibitor for AML Characterized Using Mission Bio’s Tapestri Platform in Newly Published Study

  SOUTH SAN FRANCISCO, March 8, 2021 — Mission Bio, the life sciences company delivering single-cell resolution multi-omics tools to accelerate discoveries and improve time-to-market for new therapeutics, has announced that its Tapestri Platform was used in a new study published Friday in Blood Advances to characterize the complex clonal heterogeneity that leads to treatment resistance of the FLT3 inhibitor quizartinib in patients with acute myeloid leukemia (AML).
• Visit our NEB Virtual Booth between February 8th and 12th.

  LEIDEN, February 8, 2021 - As we are not able to meet in person during the pandemic, we set up a virtual booth this week together with New England Biolabs. This virtual booth will feature Technical tips & tricks, Scientific webinars, product news and a Live chat opportunity.
• Our Instrumentation Virtual Booth Between March 20th And 24th

  LEIDEN, February 8, 2021 - As we are not able to meet in person during the pandemic, we set up a virtual booth this week together with New England Biolabs. This virtual booth will feature Technical tips & tricks, Scientific webinars, product news and a Live chat opportunity.
• Our Instrumentation Virtual Booth Between June 26th And July 31st

  LEIDEN, February 8, 2021 - As we are not able to meet in person during the pandemic, we set up a virtual booth this week together with New England Biolabs. This virtual booth will feature Technical tips & tricks, Scientific webinars, product news and a Live chat opportunity.
• BIOKÉ and Mission Bio announce a distribution agreement for the Tapestri Platform in Benelux countries

  LEIDEN January 8, 2021 - BIOKÉ announced a signed distribution agreement with Mission Bio, the leader in single-cell DNA sequencing and multi-omics to accelerate discoveries and improve time-to-market for new therapeutics, to distribute Mission Bio’s Tapestri® solution in the Netherlands, Belgium and Luxembourg (Benelux) effective immediately.
• New England Biolabs Expands its Luna® Portfolio with One-Step Master Mix for Multiplex RT-qPCR

  IPSWICH, Mass., Oct. 1, 2020 - New England Biolabs today announced the launch of its Luna Probe One-Step RT-qPCR 4X Mix with UDG, which is optimized for the sensitive detection of target RNA sequences for probe-based applications, and allows for increased throughput by multiplexing up to five targets. The new master mix consolidates all essential components into a single tube for one-step RT-qPCR.
• Cell Signaling Technology Named a Top Charitable Company in Massachusetts by the Boston Business Journal

  DANVERS, MA (PRWEB) - September 24, 2020 - Cell Signaling Technology, Inc. (CST), a discovery technology company and leading provider of antibodies, kits, and services, was named by the Boston Business Journal (BBJ) for the 5th year in a row, as a 2020 top corporate charitable contributor in Massachusetts, at the Annual Corporate Citizenship Awards on September 10th in Boston. CST ranked 71st in Massachusetts among top charitable companies, with a total contribution of $470,000 to MA local charities. The 2020 BBJ awards recognized the top 107 companies that contributed more than $100,000 to Massachusetts’s organizations in 2019.
• Introducing Cytiva – Global Life Sciences Leader

  APRIL 1, 2020 - Cytiva, a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics, launches today. Previously GE Healthcare Life Sciences, Cytiva has nearly 7,000 employees and operations in 40 countries and is part of the Danaher Corporation Life Sciences platform.
• Tools for your virus research

  The COVID-19 public health crisis affects everyone in our global community, and many scientists are working very hard to gain more knowledge about the SARS-CoV-2 virus (previously 2019-nCoV) and develop diagnostic tests, treatments and vaccines. Crucial questions about this virus need to be answered so quick and reliable research tools matter now more than ever. We at BIOKÉ support the fight against COVID-19 by offering a range of high quality products for virus research, from viral purification kits to qPCR plates, together with our reliable technical support.

• New England Biolabs to present novel solutions to support agricultural biology at Plant and Animal Genome Meeting

  IPSWICH, Mass., Jan. 10, 2020 /PRNewswire/ -- On Tuesday, January 14th, 2020, New England Biolabs (NEB®) will be hosting a workshop to present the latest advances in next generation sequencing (NGS) sample preparation at the upcoming Plant and Animal Genome (PAG) Meeting, taking place January 11-15, 2020 in San Diego, California. The presentations will focus on novel products for DNA and RNA sample preparation, including the NEBNext Direct® Genotyping Solution, a disruptive new technology to support high-throughput molecular breeding for crop development.
• Join BIOKÉ and SoftGenetics at the ESHG in Gothenburg

  LEIDEN June 3, 2019 - The European Society for Human Genetics (ESHG) is organizing its annual conference in Gothenburg, Sweden, from June 15 – 18, 2019. More than 3.500 global researchers and clinicians will attend this European meeting. At the ESHG conference you will find the latest developments in the field of human genetics.

• BIOKÉ and GE Healthcare announce an Amersham Typhoon partnership in the BeNeLux countries

  LEIDEN April 23, 2019 - BIOKÉ, a business unit of Cell Signaling Technology Europe (CST Europe) announced that they have signed an agreement with GE Healthcare allowing BIOKÉ to distribute the GE's Amersham Typhoon Gel and Blot imaging systems in the BeNeLux countries (Netherlands, Belgium, Luxembourg), effective immediately.

• Cell Press and Cell Signaling Technology Launch Online Resource to Help Scientists Achieve Experimental and Career Success

  ATLANTA, GA (PRWEB) - March 30, 2019 – Today, at the American Association of Cancer Research conference, Cell Press, a leading publisher of over 40 primary research and review journals, and Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, are excited to announce a new educational resource that will make it easier for biology students and researchers to navigate their careers, get published, and strengthen their laboratory skills to enable experimental success. The new resource is entitled Cell Mentor™.

• CiteAb Names Cell Signaling Technology “Life Science Reagent Supplier of the Year” and “Antibody Validation Initiative”

  Danvers, MA – March 7, 2019 - Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, today announced they have been named the winner of the 2019 CiteAb awards for Life Science Reagent Supplier of the Year and Antibody Validation Initiative, recognizing the company’s efforts in proactively engaging in a number of validation initiatives designed to improve the quality and quantity of data available to researchers.

• BIOKÉ and OLS OMNI Life Science Announce a Distribution Agreement for The BeNeLux countries

  LEIDEN, January 14, 2019 - BIOKÉ, a business unit of Cell Signaling Technology Europe (CST Europe), announced it has signed a distribution agreement with OLS OMNI Life Science GmbH & Co KG, a leading manufacturer and distributor of cell culture and cell assay systems for Life Science research and drug development, to distribute OLS' CERO benchtop 3D incubator and bioreactor and OLS' CASY Cell Counter and Analyzer in the Netherlands, Belgium and Luxembourg.

• SoftGenetics releases new Enlightened Probabilistic Mixture Analysis Software 'MaSTR' for Forensic DNA Analysis

  November 27, 2018 State College - SoftGenetics announced the availability of its new MaSTRTM Probabilistic Mixture Analysis Software. MaSTR software performance has been validated by Dr. Michael Adamowicz, Director of the Forensic Science Program at the University of Nebraska. He was formerly a faculty member and forensic science coordinator for the Henry C Lee College of Criminal Justice and Forensic Sciences at the University of New Haven, and was also a member of the SWGDAM Mixture Committee which develops and writes mixture analysis guidelines
• Cell Signaling Technology Earns Two Life Science Industry Awards (LSIA)

  DANVERS, MA, November 13, 2018 - Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, was honored to receive a Life Science Industry Award for both Best Digital Advertising and Most Responsive Customer Service. CST was one of 22 companies nominated and honored as a life science leader at the 2018 Life Science Industry Awards Ceremony in San Diego California on November 6, 2018.

   

• BIOKÉ on National Television!

  LEIDEN October 19, 2018 - On Sunday October 14, 2018 we were on Dutch national television in a special about the World of Technology & Science (WOTS) exposition in Utrecht. How great is that!? Watch here the 2 minute interview about the innovative contributions of BIOKÉ to Life Science research.
• Cell Signaling Technology Licenses PTMScan to Genentech to Enable Discovery Proteomics Research

  DANVERS, MA (PRWEB) – September 28, 2018 Cell Signaling Technology (CST) a leading provider of antibodies, kits, and services, announced that Genentech, a member of the Roche Group, has licensed proprietary PTMScan® technology from CST, further enabling discovery proteomics research.
• Hit Your Target at the WOTS

  Join BIOKÉ at the World of Technology & Science in Utrecht! It is only a few days away until this tradeshow takes place in the Jaarbeurs Utrecht in the Netherlands.
  You are more than welcome at our orange BIOKÉ booth #7D118. We are excited to be there and show you our latest innovations!
• Cell Signaling Technology Named a Top Charitable Company in Massachusetts by the Boston Business Journal

  DANVERS, MA (PRWEB) – September 25, 2018 The Boston Business Journal (BBJ) named cell Signaling Technology (CST), a worldwide provider of antibodies, as a 2017 top corporate charitable contributor in Massachusetts. Announced at the 13th Annual Corporate Citizenship Awards on September 6th at Fenway Park in Boston, CST ranked 80th in Massachusetts among top charitable companies, with a total contribution of $325,000 to MA local charities. The 2018 BBJ awards recognized the top 100 companies who contributed more than $100,000 to Massachusetts’s organizations in 2017.
• Cell Signaling Technology, Selling Direct-to-Scientists in England, Scotland & Wales

  DANVERS, MA (PRWEB) – September 5, 2018, Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services is delighted to announce it will now offer its products direct-to-scientists in mainland U.K. (England, Scotland, and Wales) as of January 1, 2019.
• New England Biolabs Launches NEBNext Direct Custom Ready Panels for Efficient Targeted Re-sequencing

  IPSWICH, MA (July 10, 2018) — New England Biolabs (NEB^®) today announced the launch of the NEBNext Direct Custom Ready Panels. The new panels — coupled with the proprietary NEBNext Direct target enrichment technology — enable the rapid development and deployment of a customized target enrichment panel by allowing users to select from an extensive library of genes to produce sequencing data with high specificity and coverage uniformity.

• New England Biolabs® Scientists Push the Limits of Golden Gate Assembly

  IPSWICH, Mass., June 11, 2018 /PRNewswire/ -- Some of today's most exciting molecular biology engineering — including the creation of customized CRISPR/Cas9 and TALEN constructs for genome editing — are led by synthetic biologists. These scientists are using methods such as Golden Gate Assembly. This molecular cloning technique uses a combination of Type IIS restriction enzymes and DNA ligase to assemble multiple DNA fragments simultaneously in a rapid "one-pot" reaction.

• Join BIOKÉ and SoftGenetics at the EHSG in Milan

  LEIDEN June 13, 2018 - The European Society for Human Genetics (ESHG) is organizing its annual conference in Milan, Italy, from June 16 – 19, 2018. More than 2.500 global researchers and clinicians will attend this European meeting. At the ESHG conference you will find the latest developments in the field of human genetics.

• New England Biolabs® Launches New NEBNext® Single Cell/Low Input RNA Library Prep Kit for Increased Transcript Detection with Ultra-low Input Amounts

  IPSWICH, Mass., June 14, 2018 /PRNewswire/ -- New England Biolabs (NEB®) today announced the release of the NEBNext® Single Cell/Low Input RNA Library Prep Kit for Illumina®. This new kit incorporates an optimized template switching protocol— as well as NEB's Ultra™ II FS enzymatic DNA fragmentation technology— to produce full-length transcript sequence-ready libraries from single cells and ultra-low input RNA.

• Cell Signaling Technology Expands in China

  DANVERS, MA (PRWEB) – April 5, 2018, Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, has opened a new office in Shanghai China to support the rapidly expanding China life science market and the growth of the CST business in the country.

• Clinical trial of TNF-α antagonist for severe cutaneous adverse reactions uses the NovoCyte®

  Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCARs) involving keratinocyte apoptosis and detachment of the epidermis. Current treatments, which include the use of corticosteroids, are controversial in their effectiveness. Numerous studies have demonstrated that the mechanism of SJS-TEN involves effector cytotoxic T lymphocytes (CTLs). In addition, treatment with anti–TNF-α biologic agents appears to be beneficial in patients with TEN and TEN-like acute cutaneous lupus erythematosus. However a randomized, systemic trial had not yet been run. 

• CiteAb Names Cell Signaling Technology "Antibody Company of the Year" and "Antibody Company Succeeding in Cancer Biology"

  FEBRUARY 15, 2018, DANVERS, MA  –  Cell Signaling Technology, Inc. (CST), a leading provider of antibodies, kits, and services, is honored with the 2018 CiteAb Award for “Antibody Company of the Year” and “Antibody Company Succeeding in Cancer Biology.” CST was also highly commended for the “Chemical Probes Supplier to Watch” and “Antibody Company with Sustained Success in China.” The CiteAb Antibody Awards aim to celebrate the very best suppliers, reagents, and individuals in the research antibody sector, recognizing the efforts that are made to progress science.

• New England Biolabs® Launches NEBNext® Ultra™ II FS Kit for Robust Enzyme-based DNA Fragmentation and Library Preparation with as Little as 100 pg of Input DNA

  Ipswich, MA, USA (November 7, 2017) — New England Biolabs (NEB®) today announced the release of the NEBNext Ultra II FS DNA Library Prep Kit for next generation sequencing (NGS). This new kit employs a novel enzymatic fragmentation system that combines fragmentation, end repair and dA-tailing in a single tube, and utilizes a single protocol regardless of input amount or GC content.

• General Manager of Cell Signaling Technology China, Jay Dong, is Elected Co-President of Chinese Society for Cell Biology’s Academia-Industry Consortium for Innovation and Entrepreneurship.

  Xiamen, China – November 2, 2017 - Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, has announced that Jay Dong, General Manager of its China operations, has been elected Co-President of the Chinese Society for Cell Biology’s Academia-Industry Consortium for Innovation and Entrepreneurship. This consortium was formed to support translation of basic research into translational medicine. Dong was inaugurated by Dr. Yeguang Chen, President of Chinese Society for Cell Biology (CSCB) at CSCB 2018 Conference in Xiamen, China.

• Brooks Automation Expands Sample Management Consumables Range Through the Acquisition of 4titude, Ltd.

  CHELMSFORD, Mass., October 5th, 2017 – Brooks Automation, Inc. announced today that it has acquired 4titude, Ltd., a privately-held manufacturer of scientific consumables for biological sample materials used in a variety of genomic and DNA analytical applications. Based in Surrey, England and over 12 years of operations and approximately 85 employees, 4titude is widely recognized for its innovative range of Polymerase Chain Reaction (PCR) plates, seals and related bench-top instrumentation. 4titude has delivered consistent growth over the last 5 years with sales and distribution globally to 1200 customers in 50 different countries.

• Cell Signaling Technology Announces European Operations Changes

  Danvers, MA – September 5, 2017 – Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, has announced changes in part of its European operations. On January 1st, 2018, CST will now deal directly with its customers in Germany and Austria.

• SoftGenetics LLC Acquires Assets of Mitotyping Technologies

  August 18, 2017 State College PA - SoftGenetics announced that it has purchased the assets of Mitotyping Technologies, originally founded by Terry Melton, from Health Network laboratories of Allentown PA. The addition of Mitotyping Technologies furthers SoftGenetics goal of becoming a dominant source to the world-wide DNA forensic community, which in addition to Mitotyping Technologies includes software tools for STR Analysis, Mitochondrial and STR analysis of nextgeneration data and the soon to be released MaSTR™ continuous mixture probabilistic software.

• First Successful Colorimetric LAMP Experiment Performed on International Space Station Opens Up New Possibilities for DNA-based Diagnostics in Outer Space

  IPSWICH, MA, USA (August 1, 2017) — Detecting a specific DNA sequence outside of the laboratory, without bulky equipment or even electricity, may seem unlikely. However, astronauts aboard the International Space Station (ISS) did just that using a technique developed by New England Biolabs (NEB).

• New England Biolabs® joins EMBL's Corporate Partnership Programme

  IPSWICH, Mass. and HEIDELBERG, Germany, July 25, 2017 /PRNewswire/ -- The EMBL Advanced Training Centre (ATC) welcomes New England Biolabs (NEB®) as its newest member of their Corporate Partnership Programme. Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry, NEB is a recognized world leader in the discovery, development and commercialization of recombinant and native enzymes for genomic research.

• Earlham Institute Taps New England Biolabs® to Tackle RNA from Challenging Sample Types

  Ipswich, MA, USA and Norwich, UK (June 7th, 2017) – In its mission to tackle global challenges through life science research, the Earlham Institute (Norwich, UK) faces unique problems raised through the sheer breadth of biological samples that it works with. Samples that the institute processes can come from any number of species of plant, animal, or microbial organism.

• New England Biolabs® Launches New NEBNext® Ultra™ II RNA Kits for Streamlined NGS Library Preparation with as Little as 5 ng of Total RNA

  IPSWICH, Mass., May 30, 2017 - The kits are compatible with poly(A) mRNA isolation and ribosomal RNA (rRNA) depletion, and libraries can be constructed from a substantially broader input range (5 ng to 1 µg of total RNA) at high yields. New Ultra II technology addresses lower input amounts and challenging sample types for Illumina® next generation sequencing systems.

• Cell Signaling Technology Recycles 4,400 Pounds of Glove Waste Through Innovative Program

  ROSWELL, Ga. June 13, 2017 – As a life sciences company, Cell Signaling Technology (CST) uses about 200,000 pairs of gloves each year. But that glove waste no longer goes into a landfill. CST diverts it through an innovative program that has enabled the company to recycle more than 4,400 pounds of gloves, which are then turned into flower pots, lawn furniture, and other products.

• CiteAb Names Cell Signaling Technology “Researchers’ Choice” and “PTM Antibody Company of the Year”

  February 10, 2017, Danvers, MA — Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, was honored with the 2017 CiteAb Award for “PTM Antibody Company of the Year” and for a third year in a row with the award for “Researchers’ Choice.” CST was also a close runner-up for the “Antibody Company of the Year” award. The CiteAb Antibody Awards aim to celebrate the very best suppliers, reagents, and individuals in the research antibody sector, recognizing the efforts that are made to progress science.

• First Commercially Available Software for Forensic Mitochondrial Analysis from NGS Reads

  January 26, 2017, State College PA - SoftGenetics announced the availability of its new GeneMarkerHTS software for analysis of the Mitochondrial Genome for Forensic and Clinical Research applications from High Throughput Sequencing systems.  GeneMarkerHTS is believed to be the first commercially available software developed exclusively for analysis of NGS Mitochondrial sequencing, is applicable in many cases including mass disaster, missing person, as well as clinical disease research and forensic anthropology applications.

• New ChimerMarker® software version enhances workflow at Penn Medicine

  January 19, 2017, State College PA - SoftGenetics announced the availability of the latest version of ChimerMarker software. ChimerMarker software, automated chimerism analysis software, integrates speed and accuracy with a biologist‐friendly interface. The software can be used to monitor chimerism levels in both allogeneic and autologous stem cells transplant or hematopoietic stem ...

• Cell Signaling Technology (CST) Earns Best Customer Service Award at the 2016 Life Science Industry Awards (LSIA)

  DANVERS, Mass -  November 21, 2016 – Honored as a life science leader at the 2016 Life Science Industry Awards (LSIA), Cell Signaling Technology (CST), a worldwide provider of antibodies, received Best Customer Service for its outstanding commitment to antibody quality and customer satisfaction. The LSIA recognizes .......

• CST Awards $40,000 in Science Scholarships to Four North Shore High School Juniors

  June 13, 2016 - Cell Signaling Technology (CST), CST, a worldwide provider of antibodies, is providing four high school juniors from Boston North Shore communities—Gloucester, Lynn, Peabody and Salem—with $10,000 each to pursue a college education in a science-related program.

• Cell Signaling Technology Releases Four Monoclonal Antibodies for Immunometabolism and Tumor Immunology Research - New tools to help researchers understand the tumor and immune cell crosstalk (1)

  April 12, 2016 - Cell Signaling Technology, Inc. (CST), a worldwide provider of antibodies, released four new monoclonal antibodies relevant to the rapidly growing fields of immunometabolism and tumor immunology.

• Cell Signaling Technology Announces the Release of 6 New Monoclonal Antibodies for Tumor Immunology Research.

  NOVEMBER 3, 2015, NATIONAL HARBOR, MD (US BUSINESS WIRE) Cell Signaling Technology, Inc. (CST), a worldwide provider of antibodies, announced today the release of 6 new monoclonal antibodies (mAb) for tumor immunology research. This announcement was made at the 30th annual meeting of the Society for Immunotherapy of Cancer (SITC) at National Harbor, MD November 4-8th, 2015.